Fosravuconazole is a potent triazole antifungal agent designed to treat onychomycosis, a common fungal infection of the nail. As an inhibitor of fungal cytochrome P450 enzymes, it disrupts the biosynthesis… Read more









Fosravuconazole is a potent triazole antifungal agent designed to treat onychomycosis, a common fungal infection of the nail. As an inhibitor of fungal cytochrome P450 enzymes, it disrupts the biosynthesis of ergosterol, which is critical for maintaining fungal cell membrane integrity. To support rigorous analytical testing, method validation, and quality control during pharmaceutical development, this category offers a comprehensive selection of high-quality materials. These include reference standards for the parent active pharmaceutical ingredient, as well as critical related compounds such as process-related impurities, potential degradants, stereoisomers, and stable isotope labelled compounds. Pharmaceutical laboratories rely on these specialized materials to perform accurate impurity profiling and to ensure the precision and stability of analytical assays throughout the drug lifecycle.